Cargando…

Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia

Purpose: To evaluate the difference in cerebral blood flow velocity (CBFV) in neonates with and without hyperbilirubinemia. Methods: CBFV of 70 healthy late-preterm and term newborns with unconjugated hyperbilirubinemia (UCH) reaching the threshold of phototherapy requirement was compared with 70 ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Sriparna, De, Dibyajyoti, Shukla, Ram Chandra, Kumar, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366370/
https://www.ncbi.nlm.nih.gov/pubmed/24857177
http://dx.doi.org/10.1016/j.jegh.2013.09.008
_version_ 1783560207462301696
author Basu, Sriparna
De, Dibyajyoti
Shukla, Ram Chandra
Kumar, Ashok
author_facet Basu, Sriparna
De, Dibyajyoti
Shukla, Ram Chandra
Kumar, Ashok
author_sort Basu, Sriparna
collection PubMed
description Purpose: To evaluate the difference in cerebral blood flow velocity (CBFV) in neonates with and without hyperbilirubinemia. Methods: CBFV of 70 healthy late-preterm and term newborns with unconjugated hyperbilirubinemia (UCH) reaching the threshold of phototherapy requirement was compared with 70 gestational- and postnatal age-matched controls without hyperbilirubinemia. Resistance index (RI), pulsatility index (PI), peak systolic velocity (PSV) and vascular diameter were measured in internal carotid, vertebral and middle cerebral arteries by transcranial color Doppler ultrasound at the beginning of phototherapy, after 48–72 h of starting phototherapy and at 5–7 days after its stoppage. In controls CBFV was assessed once at inclusion. Results: Both the groups were comparable. An increase in CBFV (decreased RI and PI, increased PSV and vasodilation) was observed in the UCH group. A further increase in CBFV was noticed after 48 h of phototherapy. After 5–7 days of stoppage of phototherapy, though there was a significant reduction in CBFV in mild-to-moderate UCH (serum bilirubin ⩽25 mg/dL), in severe UCH (serum bilirubin >25 mg/dL), CBFV remained increased. Four neonates developed features of acute bilirubin encephalopathy and had significantly higher CBFV compared to those with normal outcome. Conclusions: An increase in CBFV was observed in neonates with UCH compared to those without hyperbilirubinemia.
format Online
Article
Text
id pubmed-7366370
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Atlantis Press
record_format MEDLINE/PubMed
spelling pubmed-73663702020-07-28 Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia Basu, Sriparna De, Dibyajyoti Shukla, Ram Chandra Kumar, Ashok J Epidemiol Glob Health Article Purpose: To evaluate the difference in cerebral blood flow velocity (CBFV) in neonates with and without hyperbilirubinemia. Methods: CBFV of 70 healthy late-preterm and term newborns with unconjugated hyperbilirubinemia (UCH) reaching the threshold of phototherapy requirement was compared with 70 gestational- and postnatal age-matched controls without hyperbilirubinemia. Resistance index (RI), pulsatility index (PI), peak systolic velocity (PSV) and vascular diameter were measured in internal carotid, vertebral and middle cerebral arteries by transcranial color Doppler ultrasound at the beginning of phototherapy, after 48–72 h of starting phototherapy and at 5–7 days after its stoppage. In controls CBFV was assessed once at inclusion. Results: Both the groups were comparable. An increase in CBFV (decreased RI and PI, increased PSV and vasodilation) was observed in the UCH group. A further increase in CBFV was noticed after 48 h of phototherapy. After 5–7 days of stoppage of phototherapy, though there was a significant reduction in CBFV in mild-to-moderate UCH (serum bilirubin ⩽25 mg/dL), in severe UCH (serum bilirubin >25 mg/dL), CBFV remained increased. Four neonates developed features of acute bilirubin encephalopathy and had significantly higher CBFV compared to those with normal outcome. Conclusions: An increase in CBFV was observed in neonates with UCH compared to those without hyperbilirubinemia. Atlantis Press 2014 2013-10-31 /pmc/articles/PMC7366370/ /pubmed/24857177 http://dx.doi.org/10.1016/j.jegh.2013.09.008 Text en © 2013 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Basu, Sriparna
De, Dibyajyoti
Shukla, Ram Chandra
Kumar, Ashok
Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
title Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
title_full Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
title_fullStr Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
title_full_unstemmed Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
title_short Difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
title_sort difference in cerebral blood flow velocity in neonates with and without hyperbilirubinemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366370/
https://www.ncbi.nlm.nih.gov/pubmed/24857177
http://dx.doi.org/10.1016/j.jegh.2013.09.008
work_keys_str_mv AT basusriparna differenceincerebralbloodflowvelocityinneonateswithandwithouthyperbilirubinemia
AT dedibyajyoti differenceincerebralbloodflowvelocityinneonateswithandwithouthyperbilirubinemia
AT shuklaramchandra differenceincerebralbloodflowvelocityinneonateswithandwithouthyperbilirubinemia
AT kumarashok differenceincerebralbloodflowvelocityinneonateswithandwithouthyperbilirubinemia